entertainment -WSS

entertainment

author：knowledge 2025-10-04 11:35:58 - browse：682

Adam's take main illustration — Molly Ferguson/STAT

Novartis said Monday that it intends to buy MorphoSys for just under $3 billion. The deal will not close. Six months from now, or sooner, Novartis will walk away — slightly embarrassed but otherwise unscathed — happy to pay a small breakup fee to MorphoSys to avoid owning a drug for myelofibrosis that regulators turned away.

MorphoSys will not fare as well from the breakup. Its future, and that of the drug called pelabresib at the center of the deal, will be thrown into limbo.

This is all speculation on my part, but it’s supported by separate conversations with two people familiar with pelabresib and the debate inside Novartis over the MorphoSys acquisition. They requested anonymity to discuss confidential matters.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： GOP presidential candidates start declaring their loyalty

focus

WSS

Faced with fears of OxyContin misuse, sales reps touted its safety

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Abbott's new heart device gets FDA advisory panel nod

After John Oliver segment, STAT readers share their opioid

Faced with fears of OxyContin misuse, sales reps touted its safety

explore

entertainment

hotspot

What does generative AI mean for health care? We asked experts

CDC overhauls leadership of center that led response to Covid

Heart attack and stroke risk calculators need revising

Newly revealed memo details efforts to keep Trump in power following election loss

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Why don't Americans have at

Alkermes shareholders re

Eli Lilly reports tirzepatide MASH success during Q4 earnings

BioMarin wins approval for gene therapy to treat hemophilia A

Some of the ways extreme heat will change life as we know it

knowledge

Timeline: Special counsel's investigation into Trump's handling of classified documents

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

Artificial intelligence use in health care faces greater scrutiny in 2024

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

CDC overhauls leadership of center that led response to Covid

Pharma budget tightening trickles down to Doximity

focus

focus

entertainment

explore